Rhodiola rosea review

The Natac scientific team led by José Carlos Quintela have just published a review of Rhodiola rosea in the medical journal Molecules (MDPI) in June.

The literature analysis reviews 21 separate clinical studies into rhodiola’s effectiveness and discusses the plant's activity across the five key areas of: neuroprotection, anxiety and depression, physical strength and endurance, cardio protection, and reproduction. Rhodiola´s properties as an adaptogen are discussed and its major phytochemical constituents of rosavins and salidroside are brought into clinical focus.